MicroPort Firebird 2 Registered Successfully in Uruguay
Shanghai, August 29, 2012--MicroPort Firebird2, Rapamycin-Eluting Coronary CoCr Stent System, received its first registration approval in Uruguay with validity of five years. Firebird2 is the sixth MicroPort product registered in the country after Firebird, Mustang, JIVE, Hercules-T, and Tango. Till now, Firebird2 has already received its medical product registration approval in nine countries.
Privacy settings
This website may store cookies on your browser. Cookies are mostly used to make the website work as you expect it to. No cookie will directly identify you, but it can give you a more personalized browsing experience.
MicroPort respects your privacy rights, so you can block some types of cookies. Technically non-essential cookies and tracking mechanisms, that enable us to provide you with customized offers (marketing cookies), are only used if you have given prior consent to such use.
By clicking “Save”, only the cookies you selected will be used. You can withdraw the consent that you granted here at any time by going to Cookies Settings.
For more information, please see our Cookie Policy.